secwatch.observer — SEC 8-K summary
======================================

Issuer:     AXIM BIOTECHNOLOGIES, INC. (AXIM)
CIK:        0001514946
Form:       8-K
Filed at:   2022-01-12T23:59:59+00:00
Accession:  0001096906-22-000092
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

AXIM appoints Blake N. Schroeder as director to fill vacancy, effective Jan 6, 2022
--------------------------------------------------------------------------------

- Schroeder replaces Mauricio Javier Gatto-Bellora, appointed by written consent of Series C preferred stockholder.
- Schroeder serves as CEO and Chairman of Medical Marijuana, Inc., which holds ~16.4% of AXIM common stock.
- He formerly served as COO of Forevergreen International and held roles at MonaVie; holds a J.D. and B.S. in Finance.
- No related-party transactions or arrangements exist between Schroeder and AXIM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/0001096906-22-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/axim-20220106.htm
  HTML page:      https://secwatch.observer/filing/0001096906-22-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer